Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Utility of Targeted Next-Generation Sequencing Assay to Detect Copy Number Variants Associated with Myelodysplastic Syndrome in Myeloid Malignancies
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR DIAGNOSTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-10
DOI
10.1016/j.jmoldx.2021.01.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A highly sensitive and specific workflow for detecting rare copy-number variants from exome sequencing data
- (2020) Ramakrishnan Rajagopalan et al. Genome Medicine
- Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
- (2019) Diego Carbonell et al. Cancers
- Clinical Validation of a Myeloid Next-Generations Sequencing Panel for Single-Nucleotide Variants, Insertions/Deletions, and Fusion Genes
- (2019) Iyare Izevbaye et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients
- (2019) M. Isabel Prieto-Conde et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Classification and Personalized Prognosis in Myeloproliferative Neoplasms
- (2018) Jacob Grinfeld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of copy number variation analysis for next-generation sequencing diagnostics
- (2017) Jamie M Ellingford et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Margaret R. O'Donnell et al. Journal of the National Comprehensive Cancer Network
- Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies
- (2017) Sandeep Mukherjee et al. Cancer Genetics
- A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
- (2017) Po-Han Lin et al. Cancer Medicine
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy
- (2016) Wei Shen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
- (2016) Chun Hang Au et al. Diagnostic Pathology
- Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia
- (2016) Sebastian Vosberg et al. GENES CHROMOSOMES & CANCER
- Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies
- (2016) Michael J. Kluk et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms
- (2016) Stephan Bartels et al. Oncotarget
- Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia
- (2015) Christine M. Gronseth et al. CANCER
- Next-Generation Sequencing-Based Panel Testing for Myeloid Neoplasms
- (2015) Frank C. Kuo et al. Current Hematologic Malignancy Reports
- Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol
- (2014) N. Bolli et al. HAEMATOLOGICA
- Inactivating CUX1 mutations promote tumorigenesis
- (2013) Chi C Wong et al. NATURE GENETICS
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia
- (2012) M. E. McNerney et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
- (2010) C. O'Keefe et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started